Literature DB >> 18094540

Analysis of risk epitopes of anti-neutrophil antibody MPO-ANCA in vasculitis in Japanese population.

Kazuo Suzuki1, Shigeto Kobayashi, Kazushige Yamazaki, Masaaki Gondo, Kazuo Tomizawa, Yoshihiro Arimura, Kimimasa Nakabayashi, Shoichi Ozaki, Masaharu Yoshida, Toshiharu Yoshida, Norimasa Tsusaka, Eri Muso, Tomio Okazaki, Hiroshi Hashimoto.   

Abstract

Autoantibodies to myeloperoxidase (MPO) are a subset of anti-neutrophil cytoplasmic antibody (ANCA, MPO-ANCA) detected in the sera of some patients with primary systemic vasculitis. The titer of MPO-ANCA does not always reflect disease activity and this inconsistency may be attributable to differences in epitopic specificity by MPO-ANCA among various patients with vasculitis. Epitope analysis may also explain the occurrence of MPO-ANCA in different vasculitic syndromes. We screened the sera of 148 MPO-ANCA positive patients from six vasculitic syndromes: rapidly progressive gromerulonephritis (RPGN), microscopic polyangiitis (MPA), idiopathic crescentic glomerulonephritis (I-CrGN), classic polyangiitis nodosa (cPAN), Churg-Strauss syndrome (CSS), Kawasaki disease (KD); and from patients with rheumatoid arthritis (RA) and systemic lupus erythematosus (SLE). The sera were collected by the Intractable Vasculitis Research Project Group in Japan. No serum showed epitopes La and Lb of light chain of MPO, and sera with 68.6% of patients showed a positive reaction to one or more epitopes in heavy chain of MPO. Analysis of binding level showed that RPGN, I-CrGN and MPA sera mainly reacted to the Ha epitope at the N-termimus of the MPO heavy chain, CSS sera reacted to Ha and the Hf epitope close to the C-terminus of the MPO heavy chain, KD reacted mainly to Hf, while SLE and RA sera reacted to all epitopes. These results suggest that MPO-ANCA recognizing specific regions of the N-terminus of the MPO H-chain confer an increased risk of vasculitis RPGN, I-CrGN, MPA and CSS. Furthermore, the epitopic specificity of MPO-ANCA differentiates vasculitic from non-vasculitic syndromes associated with MPO-ANCA positivity and differentiates in the cirtain type of vasculitis from various vasculitic syndromes. In particular, vasculitic syndromes associated with kidney involvement had similar epitopic reactivity which suggests that this pattern confers an increased risk of vasculitis.

Entities:  

Mesh:

Substances:

Year:  2007        PMID: 18094540     DOI: 10.1111/j.1348-0421.2007.tb04017.x

Source DB:  PubMed          Journal:  Microbiol Immunol        ISSN: 0385-5600            Impact factor:   1.955


  17 in total

Review 1.  Antineutrophil cytoplasmic autoantibodies: how are they detected and what is their use for diagnosis, classification and follow-up?

Authors:  Jan Willem Cohen Tervaert; Jan Damoiseaux
Journal:  Clin Rev Allergy Immunol       Date:  2012-12       Impact factor: 8.667

2.  AP-VAS 2012 case report: an atypical case of microscopic polyangiitis presenting with acute tubulointerstitial nephritis without glomerular change.

Authors:  Hideki Kasahara; Nakamura Hiroyuki; Masahide Shinohara; Takao Koike
Journal:  CEN Case Rep       Date:  2013-12-27

3.  Epitope specificity determines pathogenicity and detectability in ANCA-associated vasculitis.

Authors:  Aleeza J Roth; Joshua D Ooi; Jacob J Hess; Mirjan M van Timmeren; Elisabeth A Berg; Caroline E Poulton; JulieAnne McGregor; Madelyn Burkart; Susan L Hogan; Yichun Hu; Witold Winnik; Patrick H Nachman; Coen A Stegeman; John Niles; Peter Heeringa; A Richard Kitching; Stephen Holdsworth; J Charles Jennette; Gloria A Preston; Ronald J Falk
Journal:  J Clin Invest       Date:  2013-03-15       Impact factor: 14.808

4.  Epitope specificity of myeloperoxidase antibodies: identification of candidate human immunodominant epitopes.

Authors:  B F Bruner; E S Vista; D M Wynn; J A James
Journal:  Clin Exp Immunol       Date:  2011-03-14       Impact factor: 4.330

5.  Churg-Strauss syndrome with severe granulomatous angiitis and crescentic glomerulonephritis, which developed during therapy with a leukotriene receptor antagonist.

Authors:  Takahiro Kanda; Hitoshi Tanio; Chunmo Wu; Hiroji Nishihara; Fumiaki Nogaki; Takahiko Ono
Journal:  Clin Exp Nephrol       Date:  2010-07-06       Impact factor: 2.801

Review 6.  Clinicopathological insights into lupus glomerulonephritis in Japanese and Asians.

Authors:  Hitoshi Yokoyama; Hiroshi Okuyama; Hideki Yamaya
Journal:  Clin Exp Nephrol       Date:  2011-03-25       Impact factor: 2.801

7.  Restricted myeloperoxidase epitopes drive the adaptive immune response in MPO-ANCA vasculitis.

Authors:  Meghan E Free; Katherine G Stember; Jacob J Hess; Elizabeth A McInnis; Olivier Lardinois; Susan L Hogan; Yichun Hu; Carmen Mendoza; Andrew K Le; Alex J Guseman; Mark A Pilkinton; Dante S Bortone; Kristen Cowens; John Sidney; Edita Karosiene; Bjoern Peters; Eddie James; William W Kwok; Benjamin G Vincent; Simon A Mallal; J Charles Jennette; Dominic J Ciavatta; Ronald J Falk
Journal:  J Autoimmun       Date:  2019-08-02       Impact factor: 7.094

Review 8.  Update on pathogenic mechanisms of systemic necrotizing vasculitis.

Authors:  Maria I Danila; S Louis Bridges
Journal:  Curr Rheumatol Rep       Date:  2008-12       Impact factor: 4.592

Review 9.  Pathogenesis and therapeutic interventions for ANCA-associated vasculitis.

Authors:  Daigo Nakazawa; Sakiko Masuda; Utano Tomaru; Akihiro Ishizu
Journal:  Nat Rev Rheumatol       Date:  2019-02       Impact factor: 20.543

10.  The immunodominant myeloperoxidase T-cell epitope induces local cell-mediated injury in antimyeloperoxidase glomerulonephritis.

Authors:  Joshua D Ooi; Janet Chang; Michael J Hickey; Dorin-Bogdan Borza; Lars Fugger; Stephen R Holdsworth; A Richard Kitching
Journal:  Proc Natl Acad Sci U S A       Date:  2012-09-05       Impact factor: 11.205

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.